rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1-3
|
pubmed:dateCreated |
2002-9-10
|
pubmed:abstractText |
N-myristoyltransferase (NMT) is essential for the survival of eukaryotes and the production of infectious human immunodeficiency virus type-1(HIV-1) by the host cell. In this study, we found decreases in the mRNA levels of human NMT isoforms and the NMT activities in the course of HIV-1 infection in the human T-cell line, CEM. Investigating the cytotoxic effect of the novel synthetic NMT inhibitors on the chronic HIV-1 infected T-cell line, CEM/LAV-1, and the uninfected CEM, revealed that the cytotoxic effect was significantly selective for CEM/LAV-1. This was thought to be due to the difference between the NMT levels of the cell lines. In this paper, we propose that NMT may be a candidate target for anti-HIV-1-infected-cell agents.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0014-5793
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
11
|
pubmed:volume |
527
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
138-42
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12220649-Acyltransferases,
pubmed-meshheading:12220649-Adenocarcinoma,
pubmed-meshheading:12220649-Anti-HIV Agents,
pubmed-meshheading:12220649-Cells, Cultured,
pubmed-meshheading:12220649-Colonic Neoplasms,
pubmed-meshheading:12220649-Drug Design,
pubmed-meshheading:12220649-Drug Evaluation, Preclinical,
pubmed-meshheading:12220649-Enzyme Inhibitors,
pubmed-meshheading:12220649-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:12220649-HIV-1,
pubmed-meshheading:12220649-Humans,
pubmed-meshheading:12220649-RNA, Messenger,
pubmed-meshheading:12220649-T-Lymphocytes
|
pubmed:year |
2002
|
pubmed:articleTitle |
Novel strategy for anti-HIV-1 action: selective cytotoxic effect of N-myristoyltransferase inhibitor on HIV-1-infected cells.
|
pubmed:affiliation |
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-Honmachi, 862-0973, Kumamoto, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|